Cedar Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,437
Closed -$574K 78
2020
Q3
$574K Buy
7,437
+865
+13% +$66K 0.19% 117
2020
Q2
$481K Sell
6,572
-610
-8% -$43.3K 0.18% 112
2020
Q1
$477K Sell
7,182
-713
-9% -$50.3K 0.23% 100
2019
Q4
$543K Buy
7,895
+1,108
+16% +$75.5K 0.25% 122
2019
Q3
$499K Buy
6,787
+1,806
+36% +$131K 0.23% 116
2019
Q2
$357K Buy
4,981
+176
+4% +$12.5K 0.15% 134
2019
Q1
$329K Sell
4,805
-44
-0.9% -$2.84K 0.15% 134
2018
Q4
$289K Buy
4,849
+1,728
+55% +$108K 0.15% 130
2018
Q3
$209K Buy
+3,121
New +$208K 0.08% 172

Other funds holding CL

Cedar Capital's CL Position: Q4 2020 in Review

Cedar Capital sold out of Colgate-Palmolive (CL) in Q4 2020, closing a stake of 7,437 shares — an estimated $574K sold.

Cedar Capital first reported a position in CL in Q3 2018 and held it in 9 quarters. The position peaked at $574K in Q3 2020. 1,650 funds tracked by Wall St. Rank hold CL as of Q4 2020.

  • Cedar Capital reported no remaining Colgate-Palmolive position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 7,437 Colgate-Palmolive shares in Q4 2020, an estimated $574K.
  • Cedar Capital first reported a position in Colgate-Palmolive in Q3 2018 and held it in 9 quarters.
  • Cedar Capital's Colgate-Palmolive position peaked at $574K in Q3 2020.
  • 1,650 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.